European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- ((top)) -

Monograph 0478 defines tablets as solid preparations containing a single dose of one or more active substances. They are primarily produced by compressing particles but can also be made through extrusion or freeze-drying (oral lyophilisates). This general monograph covers various categories, including: . Gastro-resistant and Modified-release Tablets . Effervescent, Soluble, and Dispersible Tablets .

According to the Ph. Eur. monograph for Tablets - 0478, tablets are defined as solid dosage forms that contain one or more active pharmaceutical ingredients (APIs) compressed into a single dose. The composition of tablets may vary, but they typically consist of:

: To provide bulk and cohesive properties.

: Delayed-release preparations engineered to resist gastric fluid breakdown and release the active substance inside the intestinal tract. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Includes Effervescent , Soluble , Dispersible , and Orodispersible tablets, most of which must meet a strict disintegration limit of 3 minutes . Key Quality Control Tests

: Analysts select 30 tablets at random, split them by hand, and collect one-half from each tablet.

: This test determines whether tablets break down within a specified time when placed in a liquid medium, ensuring the drug will be available for absorption. Subdivision of Tablets (Break-marks) Gastro-resistant and Modified-release Tablets

The monograph distinguishes between several categories of tablets, each with its own specific requirements:

To optimize drug delivery and processing, APIs are combined with several functional excipient categories:

: Single-layer or multi-layer compressed formulations without a subsequent coating. Critical Quality Tests

“Patient acceptability,” argued Marta, the clinical liaison, “is twofold — safety and usability. Faster disintegration for children reduces choking risk and improves dosing accuracy.”

Understanding European Pharmacopoeia (Ph. Eur.) Monograph: Tablets -0478-

A simpler, practical test for non-potent drugs where the active substance comprises a large proportion of the tablet weight. Twenty tablets are weighed individually; the average mass is calculated, and no more than two tablets deviate from the average by more than 5% (or 7.5% for larger tablets).

: The batch complies only if no more than 1 split unit out of 30 falls outside 85% to 115% of the average mass. The batch completely fails if more than one part deviates or if any single part falls outside 75% to 125% of the average mass. Crucial Quality Control (QC) Testing Standards

: This monograph generally does not apply to lozenges, oral pastes, or oral gums, nor to tablets for rectal or vaginal use (which have their own monographs like 1145 and 1164). Critical Quality Tests